Catheter based closure of ventricular septal defects

Scandinavian Cardiovascular Journal

Volumn 44, Issue 1, 2010, Pages 9-14

  Bjørnstad, Per G ^a   Smevik, Bjarne ^a   Fischer, Gunther ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Catheter treatment; Congenital heart; Septal defects; Ventricular; Ventricular septal rupture

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; CEFALOTIN; HEPARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRADYCARDIA; CHILD; CLINICAL ARTICLE; COMPLETE HEART BLOCK; HEART CATHETERIZATION; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART VENTRICLE SEPTUM DEFECT; HEMOLYSIS; HUMAN; INFANT; PACEMAKER; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; BUNDLE-BRANCH BLOCK; CLINICAL TRIAL; FEMALE; GERMANY; HEART BLOCK; HEART PACING; HEART SEPTAL DEFECTS, VENTRICULAR; MALE; MIDDLE AGED; MULTICENTER STUDY; NORWAY; RADIOGRAPHY; SEPTAL OCCLUDER; TIME; VENTRICULAR SEPTAL RUPTURE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BUNDLE-BRANCH BLOCK; CARDIAC CATHETERIZATION; CARDIAC PACING, ARTIFICIAL; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; HEART BLOCK; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; INFANT; MALE; MIDDLE AGED; NORWAY; RETROSPECTIVE STUDIES; SEPTAL OCCLUDER DEVICE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR SEPTAL RUPTURE; YOUNG ADULT;

EID: 76649107683     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017430902939876     Document Type: Article

References (25)

1. Rashkind WJ, Miller WW. Creation of an atrial septal defect without thoracotomy. A palliative approach to complete transposition of the great arteries. J Am Med Assoc. 1966; 196:991-992
2. Semb BK, Tjønneland S, Stake G, Åbyholm G. " Balloon valvulotomy" of congenital pulmonary valve stenosis with tricuspid valve insuffi ciency. Cardiovasc Radiol. 1979;2: 239-241
3. King TD, Mills NL. N onoperative closure of atrial septal defects. Surgery. 1974;75:383-388
4. Rashkind WJ, Cuaso CC. Transcatheter closure of patent ductus arteriosus. Pediatr Cardiol. 1979;1:3-7.
5. Sharafuddin MJ, Gu X, Titus JL, Urness M, Cervera-Ceballos JJ, Amplatz K. Transvenous closure of secundum atrial septal defects: Preliminary results with a new selfexpanding nitinol prosthesis in a swine model [erratum in Circulation. 1998;97:413]. Circulation. 1997;95:2162-2168
6. Sharafuddin MJ, Gu X, Titus JL, Sakinis AK, Pozza CH, Coleman CC, et al.. Experimental evaluation of a new selfexpanding patent ductus arteriosus occluder in a canine model. J Vasc Interv Radiol. 1996;7:877-887
7. Bjørnstad PG, Smevik B, Fiane AE, Tønnesen TI, Fosse E. Catheter-based closure of atrial septal defects with a newly developed nitinol double disc: An experimental study. Cardiol Young. 1997;7:220-224
8. Amin Z, Gu X, Berry JM, Bass JL, Titus JL, Urness M, et al. New device for closure of muscular ventricular septal defects in a canine model. Circulation. 1999;100:320-328
9. Bass JL, Kalra GS, Arora R, Masura J, Gavora P, Thanopoulos BD, et al.. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Cath Cardiovasc Interv. 2003;58:238-245
10. Burrell CJ, Zacharkiw LA, DeGiovanni JV. Percutaneous device closure of post-infarction ventricular septal defect with aneurysm. Heart. 2004;90:731.
11. Pesonen E, Thilen U, Sandström S, Arheden H, Koul B, Olsson S-E, et al.. Transcatheter closure of post-infarction ventricular septal defect with the Amplatzer Septal Occluder device. Scand Cardiovasc J. 2000;34:446-448
12. Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G, Gewillig M, et al.. Transcatheter closure of congenital ventricular septal defects: Results of the European Registry. Eur Heart J. 2007;28:2361-2368 (Pubitemid 47537785)
13. Bjørnstad PG, Lindberg H, Smevik B, Rian R, Sørland SJ, Tjønneland S. Balloon debandinGof the pulmonary artery. Cardiovasc Interv Radiol. 1990;13:300-303
14. Bjørnstad PG, Smevik B. Catheter-based closure of a perimembranous ventricular septal defect using the Amplatzer occluder in a patient with right-sided heart and mirrorimaged arrangements of all organs. Cardiol Young. 2005; 15:534-536
15. Kramoh EK, Dahdah N, Fournier A, Sanatani S, Hosking M, Miró J. Invasive measurements of atrioventricular conduction parameters prior to and following ventricular septal defect closure with the amplatzer device. JInvasive Cardiol. 2008;20:212-216
16. Fischer G, Apostolopoulou SC, Rammos S, Schneider MB, Bjørnstad PG, Kramer HH. The Amplatzer Membranous VSD Occluder and the vulnerability of the atrioventricular conduction system. Cardiol Young. 2007;17:499-504.
17. Rao PS. P erimembranous ventricular septal defect closure with the Amplatzer device. JInvasive Cardiol. 2008;20:217-218
18. Holzer R, D E Giovanni J, Walsh KP, Tometzki A, Goh TH, Hakim F, et al.. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: Immediate and midterm results of an international registry. Cath Cardiovasc Interv. 2006;68:620-628
19. Fu YC, Bass J, Amin Z, Radtke W, Cheatham JP, Hellenbrand WE, et al.. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Results of the U.S. phase I trial. J Am Coll Cardiol. 2006;47:319-325
20. Masura J, Gao W, Gavora P, Sun K, Zhou AQ, Jiang S, et al.. Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: Multicenter follow-up study. Pediatr Cardiol. 2005;26:216-219
21. Bol-Raap G, Weerheim J, Kappetein AP, Witsenburg M, Bogers AJ. Follow-up after surgical closure of congenital ventricular septal defect. Eur J Cardiothorac Surg. 2003; 24:511-515
22. Wilson W, Taubert KA , Gewitz M, Lockhart PB, Baddour LM, Levison M, et al.. Prevention of Infective Endocarditis. Guidelines from the American Heart Association. A Guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group . Circulation . 2007.
23. Holzer R, Balzer D, Cao Q-L, Lock K, H ijazi ZM. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder. J Am Coll Cardiol. 2004;43:1257-1263
24. Poulsen SH, Praestholm M, Munk K, Wierup P, Egeblad H, Nielsen-Kudsk JE. Ventricular septal rupture complicating acute myocardial infarction: Clinical characteristics and contemporary outcome. Ann Thorac Surg. 2008;85:1591-1596
25. Holzer R, Balzer D, Amin Z, Ruiz CE, Feinstein J, Bass J, et al.. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry. Cath Cardiovasc Interv. 2004; 61:196-201. (Pubitemid 38160617)